Articles, guides, and regulatory updates from our community.
New research suggests SS-31 (Elamipretide) may modulate alpha-synuclein aggregation and restore mitochondrial function in Parkinson's-related models.
By Peptide Association Research Team
New research suggests the peptide SS-31 (Elamipretide) may modulate α-synuclein aggregation and restore mitochondrial function linked to Parkinson's disease.
By Peptide Association Research Team